Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Sep 2, 2015IFA
In collaboration with U.S. retail jewelry company REEDS Jewelers, LG Electronics (LG) will introduce a premium limited edition smartwatch, LG Watch Urbane Luxe. This luxurious wearable was...
-
Sep 2, 2015HC Wanwright
Aethlon Medical, Inc. (Nasdaq: AEMD), today announced that Jim Joyce, Chairman and CEO, will be presenting at the Rodman & Renshaw 17th Annual Global Investment Conference in New York, NY at 9:35...
-
Sep 2, 2015LA Auto Show 2015 - show news releases and content
LOS ANGELES, CA (September 2, 2015) – The Los Angeles Auto Show (LA Auto Show®) announced today that 30 world debuts, totaling 50 vehicle unveilings overall, will be introduced in front of...
-
Sep 2, 2015LA Auto Show 2015 - show news releases and content
The Los Angeles Auto Show (LA Auto Show®) announced today that 30 world debuts, totaling 50 vehicle unveilings overall, will be introduced in front of media, analysts and automotive industry...
-
Sep 2, 2015CTIA Super Mobility
Rohde & Schwarz, Inc., an industry leader in mobile wireless test, has announced that it will demonstrate several key test systems for the development and test of 5G components and systems at this...
-
Sep 2, 2015CTIA Super Mobility
Simgo's first virtual SIM for Smartphones announced today it was named a finalist in the Mobile Enterprise Innovation of CTIA's MobITs Awards competition. Enhancing enterprise performance,...
-
Sep 2, 2015HC Wanwright
Delcath Systems, Inc. (NASDAQ: DCTH), a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announces...
-
Sep 2, 2015HC Wanwright
CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to reduce deadly uncontrolled inflammation in...
-
Sep 2, 2015HC Wanwright
OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that members of its leadership team will be making...